Cell Death and Disease (Dec 2022)

Migration deficits of the neural crest caused by CXADR triplication in a human Down syndrome stem cell model

  • Huanyao Liu,
  • Shanshan Huang,
  • Weijia Wang,
  • Huiyan Wang,
  • Weijun Huang,
  • Zhichen Zhai,
  • Ding Wang,
  • Yubao Fan,
  • Jiaqi Sun,
  • Dairui Li,
  • Weicheng Chiu,
  • Xingqiang Lai,
  • Jixiao Zeng,
  • Qiong Ke,
  • Tao Wang,
  • Andy Peng Xiang,
  • Yong Yuan,
  • Xinchun Zhang,
  • Weiqiang Li

DOI
https://doi.org/10.1038/s41419-022-05481-6
Journal volume & issue
Vol. 13, no. 12
pp. 1 – 12

Abstract

Read online

Abstract Down syndrome (DS) is the most common chromosomal abnormality in live-born infants and is caused by trisomy of chromosome 21. Most individuals with DS display craniofacial dysmorphology, including reduced sizes of the skull, maxilla, and mandible. However, the underlying pathogenesis remains largely unknown. Since the craniofacial skeleton is mainly formed by the neural crest, whether neural crest developmental defects are involved in the craniofacial anomalies of individuals with DS needs to be investigated. Here, we successfully derived DS-specific human induced pluripotent stem cells (hiPSCs) using a Sendai virus vector. When DS-hiPSCs were induced to differentiate into the neural crest, we found that trisomy 21 (T21) did not influence cell proliferation or apoptosis. However, the migratory ability of differentiated cells was significantly compromised, thus resulting in a substantially lower number of postmigratory cranial neural crest stem cells (NCSCs) in the DS group than in the control group. We further discovered that the migration defects could be partially attributed to the triplication of the coxsackievirus and adenovirus receptor gene (CXADR; an adhesion protein) in the DS group cells, since knockdown of CXADR substantially recovered the cell migratory ability and generation of postmigratory NCSCs in the DS group. Thus, the migratory deficits of neural crest cells may be an underlying cause of craniofacial dysmorphology in individuals with DS, which may suggest potential targets for therapeutic intervention to ameliorate craniofacial or other neural crest-related anomalies in DS.